Investing.com - Financial Markets Worldwide

Astrana Health stock hits 52-week low at $23.12

Published 18/07/2025, 15:50
Astrana Health stock hits 52-week low at $23.12
ASTH
-0.71%

Astrana Health Inc’s stock has reached a 52-week low, trading at $23.12. This marks a significant downturn for the company, as its stock price has decreased by 52% over the past year. Despite the decline, InvestingPro analysis indicates the company maintains strong fundamentals with 54.8% revenue growth and a "GOOD" overall financial health score. The decline reflects a challenging period for Astrana Health, as it navigates a competitive healthcare sector and broader market conditions. Analysts maintain a bullish outlook, with targets suggesting significant upside potential. According to InvestingPro’s Fair Value analysis, the stock appears undervalued at current levels, with additional insights available in the comprehensive Pro Research Report covering this healthcare provider.

In other recent news, Astrana Health reported its Q1 2025 earnings, which revealed an earnings per share (EPS) of $0.14, missing the forecasted $0.30. The company’s revenue also fell short of expectations, coming in at $620.4 million compared to the anticipated $628.11 million. Despite the earnings miss, Astrana Health demonstrated a significant 53% year-over-year revenue increase, driven by strategic expansions and operational efficiencies. The company has announced strategic expansions into Nevada and Texas, which are currently underway. Additionally, Astrana Health is in the process of acquiring Prospect Health, a move expected to significantly expand its provider network in Southern California. The transaction is anticipated to contribute around $81 million in adjusted EBITDA, with expected synergies between $12 million to $15 million. In leadership news, Astrana Health appointed Sherry McBride as Chief Operating Officer, along with other key executive positions to strengthen its operations and care model integration. These developments reflect the company’s ongoing strategy to enhance its capabilities and expand its footprint in the healthcare sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.